Latest / Tech IPO Conversations with Fexingo: Public Software Companies and Capital Markets / How Post-IPO Companies Use Reverse Stock Splits to Avoid Delisting
Transcript
- Lucas: If your stock falls below a dollar and stays there for thirty consecutive trading days, Nasdaq sends you a notice. You get a hundred and eighty days to fix it, and one of the most common fixes is a reverse stock split. Luna: And a reverse split—just to be clear for anyone who hasn't seen one—is when a company takes, say, ten existing shares and turns them into one. The share price multiplies by ten, but your total value stays the same, assuming nothing else moves. Lucas: Exactly. No value is created or destroyed by the split itself. But the optics… they're brutal. A reverse split is often read as a distress signal. It says 'our stock was so low we couldn't keep our listing without doing this.' Lucas: And yet, a surprising number of post ipo companies end up doing one. According to data from Wilshire Associates, about one in five companies listed between 2020 and 2024 have executed a reverse split within their first three years as a public company. That's higher than any prior cohort. Luna: Right, because that wave included a lot of SPACs and early-stage biotechs that came public before they had real revenue. When the market rotated away from growth stories in 2022 and 2023, those stocks got crushed. Lucas: Take a look at the ARK Genomic Revolution ETF, ticker A-R-K-G. It's up almost eighteen percent in the past five days as of today, June 29th, 2026. But that fund holds a lot of small biotech names that have done reverse splits just to survive. The underlying companies didn't suddenly get better—the market just decided to rotate back into risk. Luna: So a reverse split can be a lifeline, but it's also a signal that the company's equity story isn't working. Is there ever a case where it's actually a positive move? Lucas: Rarely, but yes. Sometimes a company's share price drops for reasons unrelated to its fundamentals—a sector-wide selloff, a one-time accounting charge, a short-seller attack that later gets debunked. If the business is sound, a reverse split can clear the compliance hurdle and let management focus on operations instead of the stock price. Lucas: There's also the institutional investor angle. Many pension funds and mutual funds have rules against buying stocks below five dollars. A reverse split can lift the stock above that threshold and open the door to a whole new pool of capital. Luna: But the data on post-split performance is sobering, right? I remember a study from the University of Florida that found reverse-split stocks underperform the market by roughly ten percent in the year after the split. Lucas: That's the classic finding. And the mechanism is pretty straightforward. Companies that need a reverse split are usually companies in distress. The split doesn't fix the underlying business. So the stock tends to drift back down, and eventually, many of them do get delisted anyway. Lucas: But there are exceptions. Take a company that does a reverse split and then delivers a positive catalyst—a new product approval, a surprise profitable quarter, an acquisition. That can break the cycle. Luna: One example that comes to mind is Rivan, ticker R-I-V-N. Their stock is up nearly thirteen percent in the past five days. They haven't done a reverse split, but they've been hovering around single digits for a while. If they ever needed one, the question would be whether the market would trust them after. Lucas: And that's the crux of it. The market interprets a reverse split as management acknowledging they can't support the stock price naturally. Even if the logic is sound, the stigma is real. Luna: So what should a founder or CFO do if they're staring at a compliance notice? Is a reverse split the only option? Lucas: No. You can also try to buy back shares, which boosts earnings per share and can lift the stock price organically. Or you can do a rights offering, or find a strategic investor willing to buy a block at a premium. Some companies have even switched exchanges—from Nasdaq to the NYSE American, which has lower minimum bid requirements. Lucas: But those alternatives take time and often require a stock price that isn't already in freefall. When you're at fifty cents and the clock is ticking, a reverse split is the quickest tool in the toolbox. Luna: And the mechanics are straightforward. Shareholders have to approve it, but most proxy fights for reverse splits pass easily because the alternative—delisting—is worse for everyone. Lucas: Right. Delisting is catastrophic. It triggers loan covenants, institutional selling, and a near-total loss of liquidity. A reverse split at least gives you a fighting chance. Lucas: I want to be honest about something here. A lot of the research we do for episodes like this—digging into data, finding the right examples—it's made possible by listeners who chip in a few dollars a month at buy me a coffee dot com slash fexingo. No ads, no sponsors, just listener support. Luna: Yeah, it's a small group, but it makes a big difference. If you've been getting value out of these conversations, consider throwing in a couple bucks. It keeps us independent. Lucas: Alright, back to reverse splits. One strategy that's become more popular in the past couple years is the so-called 'controlled reverse split' where the company combines the split with a stock buyback announcement at the same time. The idea is to signal confidence and cushion the post-split price. Luna: Does that actually work? I can think of a couple SPACs that tried that in 2024 and the stock still slid. Lucas: Mixed results. The buyback helps in the short term, but if the business isn't generating cash, the buyback is just burning more capital. Eventually, the market sees through it. Lucas: What I find interesting is the sector breakdown. Biotech and SPACs account for the vast majority of reverse splits among post ipo companies. Biotech because many of them have no revenue and rely on trial results that are binary. SPACs because they often came public with overly optimistic projections. Luna: And the ARKG surge we mentioned earlier—does that suggest the biotech reverse-split cycle might turn? If investor sentiment is coming back, maybe those companies can avoid a second reverse split. Lucas: Possibly. The ARKG run is real—up almost eighteen percent in five days. But that's an ETF move, not necessarily a fundamental improvement in the underlying biotech names. Many of them still have the same cash burn problems they had a month ago. Luna: So the lesson might be: don't confuse a sector rotation with a turnaround. Reverse splits are structural, not cyclical. Lucas: Exactly. If your business model relies on reverse splits to stay listed, you have a business model problem, not a stock price problem. Luna: What about companies that do multiple reverse splits? I've seen some that have done two or three in a decade. Lucas: That's a red flag. If you do a reverse split and the stock goes back below a dollar, you're essentially in a death spiral. Each split reduces the number of shares, making the stock more volatile and less attractive to retail investors. Eventually, you run out of room. Lucas: Nasdaq has rules to prevent abusive serial splits, too. If a company does a reverse split and then the stock drops below the minimum again within a year, they can face immediate delisting without a cure period. Luna: Good. That keeps the market from becoming a haven for zombie stocks. Lucas: Alright, I think the takeaway for founders and CFOs is this: a reverse split is a tactical tool, not a strategic solution. If you're considering one, make sure you have a credible plan to grow into the new share price. Otherwise, you're just kicking the can down the road. Luna: And for investors, keep an eye on companies that announce reverse splits. It's not an automatic sell, but it's a strong signal to dig deeper into the fundamentals. Lucas: Next episode, we'll look at something a little more upbeat—how some post ipo companies are using regular-way stock buybacks to create a floor under their stock without resorting to a split. See you then.